trending Market Intelligence /marketintelligence/en/news-insights/trending/SoRewF3ZjpwP9BUFP84Cow2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

UK's NHS to fund patients for Second Sight's 'bionic eye'

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


UK's NHS to fund patients for Second Sight's 'bionic eye'

Second Sight Medical Products Inc. said U.K.'s National Health Service would fund blind patients suffering from retinitis pigmentosa to receive treatment with the company's Argus II retinal prosthesis system, or "bionic eye."

The product would be funded via the commissioning through an evaluation program, which is designed for treatments showing promise while new clinical and patient experience data are collected within a formal evaluation program.

Argus II is reimbursed under a similar program called Forfait Innovation in France.